Waters Corporation (NYSE:WAT) announces that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies. “Adding the innovative low-sample-volume, high-throughput technology from Halo Labs provides analysis for a broad range of sample types and volumes, enabling earlier insights during therapy development and greater safety during manufacturing,” said Dr. Udit Batra, President and Chief Executive Officer, Waters Corporation.
Read the full article: Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio //
Source: https://www.prnewswire.com/news-releases/waters-acquires-halo-labs-expanding-biological-analysis-portfolio-302461826.html